MassMutual Private Wealth & Trust’s CureVac CVAC Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-32	Closed	–	–	1651
2022 Q2	$0	Buy	+32	New	+$529	﹤0.01%	1553

Other funds holding CVAC

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MassMutual Private Wealth & Trust's CVAC Position: Q3 2022 in Review

MassMutual Private Wealth & Trust sold out of CureVac (CVAC) in Q3 2022, closing a stake of 32 shares.

MassMutual Private Wealth & Trust first reported a position in CVAC in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 83 funds tracked by Wall St. Rank hold CVAC as of Q3 2022.

MassMutual Private Wealth & Trust reported no remaining CureVac position as of Q3 2022 after selling out during the quarter.
MassMutual Private Wealth & Trust sold 32 CureVac shares in Q3 2022.
MassMutual Private Wealth & Trust first reported a position in CureVac in Q2 2022 and held it in 1 quarter.
MassMutual Private Wealth & Trust's CureVac position peaked at $0 in Q2 2022.
83 funds tracked by Wall St. Rank held CureVac as of Q3 2022.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2022, filed 7 Oct 2022.